Roles of the respective loops at complementarity determining region on the antigen-antibody recognition

For the rational design of antibody, it is important to clarify the characteristics of the interaction between antigen and antibody. In this study, we evaluated a contribution of the respective complementarity determining region (CDR) loops on the antibody recognition of antigen by performing molecular dynamics simulations for 20 kinds of antigen-antibody complexes. Ser and Tyr showed high appearance rates at CDR loops and the sum of averaged appearance rates of Ser and Tyr was about 20-30% at all the loops. For example, Ser and Tyr occupied 23.9% at the light chain first loop (L1) and 23.6% at the heavy chain third loop (H3). The direct hydrogen bonds between antigen and antibody were not equally distributed over heavy and light chains. That is, about 70% of the hydrogen bonds were observed at CDRs of the heavy chain and also the direct hydrogen bond with the shortest distance mainly existed at the loops of the heavy chain for all the complexes. It was revealed from the comparison in contribution to the binding free energy among CDR loops that the heavy chain (especially at H2 and H3) had significant influence on the binding between antigen and antibody because three CDR loops of the heavy chain showed the lowest binding free energy (ΔGbind) in 19 complexes out of 20. Tyr in heavy chain (especially in H2 and H3) largely contributed to ΔGbind whereas Ser hardly contributed to ΔGbind even if the number of the direct hydrogen bond with Ser was the fourth largest and also the appearance rate at CDR was the highest among 20 kinds of amino acid residues. The contributions ofTrp and Phe, which bear aromatic ring in the side chain, were often observed in the heavy chain although the energetic contribution of these residues was not so high as Tyr. The present computational analysis suggests that Tyr plays an outstanding role for the antigen-antibody interaction and the CDR loops of the heavy chain is critically important for antibody recognition of antigen.

[1]  J. Reichert.  Antibodies to watch in 2013 , 2013, mAbs.

[2]  L. Presta,et al.  Structural insight into how an anti-idiotypic antibody against D3H44 (anti-tissue factor antibody) restores normal coagulation. , 2003, Journal of molecular biology.

[3]  J. Fontecilla-Camps,et al.  Structural features of the interaction between an anti-clonotypic antibody and its cognate T-cell antigen receptor. , 1999, Journal of molecular biology.

[4]  J. Fontecilla-Camps,et al.  The three‐dimensional structure of a T‐cell antigen receptor VαVβ heterodimer reveals a novel arrangement of the Vβ domain , 1997 .

[5]  Xiaojie Xu,et al.  Predictions of Binding of a Diverse Set of Ligands to Gelatinase-A by a Combination of Molecular Dynamics and Continuum Solvent Models , 2002 .

[6]  Jianzhong Chen,et al.  Computational Studies of Difference in Binding Modes of Peptide and Non-Peptide Inhibitors to MDM2/MDMX Based on Molecular Dynamics Simulations , 2012, International journal of molecular sciences.

[7]  B. Stoddard,et al.  Structure of a factor VIII C2 domain-immunoglobulin G4kappa Fab complex: identification of an inhibitory antibody epitope on the surface of factor VIII. , 2001, Blood.

[8]  K. Tsumoto,et al.  Structural Consequences of Target Epitope-directed Functional Alteration of an Antibody , 2003, Journal of Biological Chemistry.

[9]  S. Smith‐Gill,et al.  X-ray snapshots of the maturation of an antibody response to a protein antigen , 2003, Nature Structural Biology.

[10]  R. Poljak,et al.  Characterization of anti-anti-idiotypic antibodies that bind antigen and an anti-idiotype. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Damien Fleury,et al.  Antigen distortion allows influenza virus to escape neutralization , 1998, Nature Structural Biology.

[12]  D. Case,et al.  Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RalGDS complexes. , 2003, Journal of molecular biology.

[13]  A. Wlodawer,et al.  Light chain somatic mutations change thermodynamics of binding and water coordination in the HyHEL-10 family of antibodies. , 2009, Molecular immunology.

[14]  L. Wyns,et al.  Antigen Specificity and High Affinity Binding Provided by One Single Loop of a Camel Single-domain Antibody* , 2001, The Journal of Biological Chemistry.

[15]  N. Dimmock,et al.  A haemagglutinin (HA1)-specific FAb neutralizes influenza A virus by inhibiting fusion activity. , 2001, The Journal of general virology.

[16]  Carol Carter,et al.  Crystal structure of dimeric HIV-1 capsid protein , 1996, Nature Structural Biology.

[17]  P. Colman,et al.  Three-dimensional structures of single-chain Fv-neuraminidase complexes. , 1998, Journal of molecular biology.

[18]  R. Poljak,et al.  Crystal structure of an Fv-Fv idiotope-anti-idiotope complex at 1.9 A resolution. , 1996, Journal of molecular biology.

[19]  Holger Gohlke,et al.  Converging free energy estimates: MM‐PB(GB)SA studies on the protein–protein complex Ras–Raf , 2004, J. Comput. Chem..

[20]  Fred Dyda,et al.  Water molecules in the antibody-antigen interface of the structure of the Fab HyHEL-5-lysozyme complex at 1.7 A resolution: comparison with results from isothermal titration calorimetry. , 2005, Acta crystallographica. Section D, Biological crystallography.

[21]  S Cusack,et al.  Mutual conformational adaptations in antigen and antibody upon complex formation between an Fab and HIV-1 capsid protein p24. , 2000, Structure.

[22]  G. Hu,et al.  The crystal structure of human angiogenin in complex with an antitumor neutralizing antibody. , 2003, Structure.

[23]  Yan Sun,et al.  Molecular mechanism of the affinity interactions between protein A and human immunoglobulin G1 revealed by molecular simulations. , 2011, The journal of physical chemistry. B.

[24]  R. Murali,et al.  Crystal structure of Taq DNA polymerase in complex with an inhibitory Fab: the Fab is directed against an intermediate in the helix-coil dynamics of the enzyme. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Masayuki Hata,et al.  Implementation of π‐π interactions in molecular dynamics simulation , 2007, J. Comput. Chem..

[26]  Sachdev S Sidhu,et al.  Molecular recognition by a binary code. , 2005, Journal of molecular biology.

[27]  D. Wigley,et al.  The third IgG-binding domain from streptococcal protein G. An analysis by X-ray crystallography of the structure alone and in a complex with Fab. , 1994, Journal of molecular biology.

[28]  Mariana Henriques,et al.  Technological progresses in monoclonal antibody production systems , 2009, Biotechnology progress.

[29]  Holger Gohlke,et al.  The Amber biomolecular simulation programs , 2005, J. Comput. Chem..

[30]  Janice M. Reichert,et al.  Which are the antibodies to watch in 2013? , 2013, mAbs.

[31]  S. Smith‐Gill,et al.  Three-dimensional structures of the free and antigen-bound Fab from monoclonal antilysozyme antibody HyHEL-63(,). , 2000, Biochemistry.

[32]  J. Antosiewicz,et al.  pH-dependent association of proteins. The test case of monoclonal antibody HyHEL-5 and its antigen hen egg white lysozyme. , 2009, The journal of physical chemistry. B.

[33]  Roland L. Dunbrack,et al.  A new clustering of antibody CDR loop conformations. , 2011, Journal of molecular biology.

[34]  L. Presta,et al.  The 1.85 A resolution crystal structures of tissue factor in complex with humanized Fab D3h44 and of free humanized Fab D3h44: revisiting the solvation of antigen combining sites. , 2001, Journal of molecular biology.

[35]  Tyuji Hoshino,et al.  Computational and statistical study on the molecular interaction between antigen and antibody. , 2014, Journal of molecular graphics & modelling.

[36]  Y. Ofran,et al.  The indistinguishability of epitopes from protein surface is explained by the distinct binding preferences of each of the six antigen-binding loops. , 2013, Protein engineering, design & selection : PEDS.

[37]  B. Atanasov,et al.  A human FVIII inhibitor modulates FVIII surface electrostatics at a VWF‐binding site distant from its epitope , 2010, Journal of thrombosis and haemostasis : JTH.

[38]  E. Waygood,et al.  Synthesis, cloning and expression of the single-chain Fv gene of the HPr-specific monoclonal antibody, Jel42. Determination of binding constants with wild-type and mutant HPrs. , 1999, Protein engineering.

[39]  Masayuki Hata,et al.  Mechanism of drug resistance due to N88S in CRF01_AE HIV-1 protease, analyzed by molecular dynamics simulations. , 2007, Journal of medicinal chemistry.

[40]  Sudha Ramaiah,et al.  π–π Interactions in Structural Stability: Role in RNA Binding Proteins , 2013, Cell Biochemistry and Biophysics.

[41]  Sachdev S Sidhu,et al.  Synthetic antibodies from a four-amino-acid code: a dominant role for tyrosine in antigen recognition. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[42]  D. Shaw,et al.  An anti-urokinase plasminogen activator receptor (uPAR) antibody: crystal structure and binding epitope. , 2006, Journal of molecular biology.

[43]  L. Prasad,et al.  The 2.5 A resolution structure of the jel42 Fab fragment/HPr complex. , 1998, Journal of molecular biology.

[44]  G. Air,et al.  Contacts between influenza virus N9 neuraminidase and monoclonal antibody NC10. , 2002, Virology.

[45]  C. Lowe,et al.  A biomimetic Protein G affinity adsorbent: an Ugi ligand for immunoglobulins and Fab fragments based on the third IgG‐binding domain of Protein G , 2013, Journal of molecular recognition : JMR.

[46]  V. Lee,et al.  Pairwise decomposition of residue interaction energies of single chain Fv with HIV-1 p17 epitope variants. , 2010, Molecular immunology.

[47]  L Wang,et al.  Molecular dynamics and free-energy calculations applied to affinity maturation in antibody 48G7. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[48]  Søren B. Padkjær,et al.  Structural analysis of B-cell epitopes in antibody:protein complexes. , 2013, Molecular immunology.

[49]  M. Karplus,et al.  CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .

[50]  Zhenqing Feng,et al.  An active murine–human chimeric Fab antibody derived from Escherichia coli, potential therapy against over-expressing VEGFR2 solid tumors , 2011, Applied Microbiology and Biotechnology.

[51]  J. Maynard,et al.  Progress towards recombinant anti-infective antibodies. , 2009, Recent patents on anti-infective drug discovery.

[52]  S. Smith‐Gill,et al.  Association energetics of cross-reactive and specific antibodies. , 2009, Biochemistry.

[53]  W. Delano.  The PyMOL Molecular Graphics System , 2002 .

[54]  B. Rost,et al.  Automated Identification of Complementarity Determining Regions (CDRs) Reveals Peculiar Characteristics of CDRs and B Cell Epitopes1 , 2008, The Journal of Immunology.

[55]  A. Takada,et al.  Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity , 2012, Proceedings of the National Academy of Sciences.

[56]  P. Martineau,et al.  Restricted diversity of antigen binding residues of antibodies revealed by computational alanine scanning of 227 antibody-antigen complexes. , 2014, Journal of molecular biology.

[57]  B. Furie,et al.  Crystal Structure of the Calcium-stabilized Human Factor IX Gla Domain Bound to a Conformation-specific Anti-factor IX Antibody* , 2004, Journal of Biological Chemistry.

[58]  Yili Li,et al.  Dissection of binding interactions in the complex between the anti-lysozyme antibody HyHEL-63 and its antigen. , 2003 .

[59]  M. Nassal,et al.  A fusion product of the complete Borrelia burgdorferi outer surface protein A (OspA) and the hepatitis B virus capsid protein is highly immunogenic and induces protective immunity similar to that seen with an effective lipidated OspA vaccine formula , 2005, European journal of immunology.

[60]  P. Kollman,et al.  Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. , 2000, Accounts of chemical research.

[61]  Sachdev S Sidhu,et al.  Tyrosine plays a dominant functional role in the paratope of a synthetic antibody derived from a four amino acid code. , 2006, Journal of molecular biology.

[62]  J. Banerjee.  Antibodies are challenged. , 2010, Indian Journal of Medical Sciences.

[63]  E. Altshuler,et al.  Generation of recombinant antibodies and means for increasing their affinity , 2010, Biochemistry (Moscow).

[64]  B. Brandsdal,et al.  Ferric uptake regulator protein: Binding free energy calculations and per‐residue free energy decomposition , 2009, Proteins.

[65]  Kouhei Tsumoto,et al.  Contribution of Asparagine Residues to the Stabilization of a Proteinaceous Antigen-Antibody Complex, HyHEL-10-Hen Egg White Lysozyme* , 2009, The Journal of Biological Chemistry.

[66]  N. Sinha,et al.  Modeling the binding sites of anti-hen egg white lysozyme antibodies HyHEL-8 and HyHEL-26: an insight into the molecular basis of antibody cross-reactivity and specificity. , 2003, Biophysical journal.

[67]  Kouhei Tsumoto,et al.  Critical contribution of VH–VL interaction to reshaping of an antibody: The case of humanization of anti‐lysozyme antibody, HyHEL‐10 , 2008, Protein science : a publication of the Protein Society.

[68]  E. Nice,et al.  Analysis of the binding of the Fab fragment of monoclonal antibody NC10 to influenza virus N9 neuraminidase from tern and whale using the BIAcore biosensor: effect of immobilization level and flow rate on kinetic analysis. , 1999, Analytical biochemistry.

[69]  S. Koide,et al.  Structural identification of a key protective B-cell epitope in Lyme disease antigen OspA. , 2000, Journal of molecular biology.